Weird health insurance concepts.
“Maybe we’ll learn a thing or two about intercompany eliminations, co-pay accumulators/maximizers, and reference-based pricing.” ~ learn more
“Maybe we’ll learn a thing or two about intercompany eliminations, co-pay accumulators/maximizers, and reference-based pricing.” ~ learn more
Earlier this year I thought it seemed admirable when sharing a related link. A reader replied with the contrarian view that predicted free tuition wouldn’t achieve the sponsor’s goals. Seems that it’s not working… “Perhaps most alarming of all, doing […]
“Genetically, I should be bald. I started to lose my hair and go gray in my late 20s. Now, at 47, I’ve got a full head of hair and ~70% of my gray is gone.” ~ learn more
“The term refers to companies that are selling a product or solution targeted to a single condition, such as headaches or diabetes or pregnancy.” This post considers the market for these employer-paid and patient-focused services. ~ learn more
“There’s a pattern in fake scammy alternative medicine. People get excited about some new herb. They invent a laundry list of effects: it improves heart health, softens menopause, increases energy, deepens sleep, clears up your skin. This is how you […]
Jared Dashevsky is an MD and publisher of the Healthcare Huddle industry newsletter. I’ve been a reader since years ago when he hated consumer CGM usage. Glad to see he’s now a fan of Nutrisense! ~ learn more
I’ve been really enjoying Derek Flanzraich’s new newsletter. “If you’re new here, every Thursday I share 5 health-related things I feel strongly about. I explore, double click, and curate healthy things so you can just live healthyish (and spend less […]
“Kevin undergoes ketamine therapy on-camera, exploring its efficacy, safety, and the science behind this controversial treatment.” I didn’t watch this whole 2-hour video. I did, however, find Dr. Jennifer Ellice to be a great communicator and this quote felt accurate: […]
“Today I’m chatting with Davis Liang at Abridge, the company that turns voice encounters in healthcare into reports, data, etc.. We’ve talked in the past about the business and product side of Abridge, but today I wanted to go a […]
Scott Alexander once wondered how the economy would handle a $12,000/yr drug that everybody wants (i.e. Ozempic). We haven’t seen the official price become the market price, though, because patent protections for the drug are currently suspended. That’s the compounding […]